GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancersPeter Sabbatini, Rakesh Kumar|Molecular Cancer Therapeutics|2009Cited by 98
Antitumor Activity of GSK1904529A, a Small-molecule Inhibitor of the Insulin-like Growth Factor-I Receptor Tyrosine KinasePeter Sabbatini, Rakesh Kumar|Clinical Cancer Research|2009Cited by 79